Imidazoline recognition sites and stomach function

Annals of the New York Academy of Sciences

Volumn 881, Issue , 1999, Pages 332-343

  Molderings, G J ^a   Burian, M ^a   Menzel, S ^a   Donecker, K ^a   Homann, J ^a   Nilius, M ^a   Gothert M ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGMATINE; GUANIDINE DERIVATIVE; IMIDAZOLINE DERIVATIVE; IMIDAZOLINE RECEPTOR; RADIOLIGAND;

BINDING AFFINITY; BINDING SITE; CONFERENCE PAPER; HELICOBACTER PYLORI; LIGAND BINDING; STOMACH; STOMACH GLAND; STOMACH JUICE; STOMACH MUSCLE;

HELICOBACTER PYLORI;

EID: 0032813812     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09377.x     Document Type: Conference Paper

References (56)

1. 2 receptor antagonists on acid secretion stimulated by imidazoline derivatives in isolated parietal cells. Eur. J. Pharmacol. 144: 67-76.
2. Tesson, F., I. Limon & A. Parini. 1992. Tissue-specific localization of mitochondrial imidazoline-guanidinium receptive sites. Eur. J. Pharmacol. 219: 335-338.
3. 3H]clonidine binding sites in rat stomach: High affinity of imidazolines, guanidines and sigma ligands. Naunyn-Schmiedeberg's Arch. Pharmacol. 351: 561-564.
4. 2-imidazoline and σ binding sites in the rat and human stomach. J. Pharmacol. Exp. Ther. 285: 170-177.
5. Blaxall, H. S., T. J. Murphy, J. C. Baker, C. Ray & D. B. Bylund. 1991. Characterization of the alpha-2C adrenergic receptor subtype in the opossum kidney and in the OK cell line. J. Pharmacol. Exp. Ther. 259: 323-329.
6. Bylund, D. B., D. C. Eikenberg, J. P. Hieble, S. Z. Langer, R. J. Lefkowitz, K. P. Minneman, P. B. Molinoff, R. R. Ruffolo & U. Trendelenburg. 1994. International union of pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46: 121-136.
7. 3H]idazoxan binding sites in human cardiovascular tissue. Br. J. Pharmacol. 122: 43-50.
8. 2-adrenoceptors. Eur. J. Pharmacol. 215: 109-117.
9. Göthert, M., M. Brüss, H. Bönisch & G. J. Molderings. Presynaptic imidazoline receptors: New developments in characterization and classification. Ann. N.Y. Acad. Sci., this volume.
10. 1-imidazoline sites in bovine adrenal medullary membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 348: 70-76.
11. Ernsberger, P., K. Westbrooks & L. Graff. 1991. Imidazole binding sites labeled by clonidine analogs (I1 sites): Putative G-protein-linked receptors. FASEB J. 5: A1066.
12. 3H]Cirazoline as a tool for the characterization of imidazoline sites. Ann. N.Y. Acad. Sci. 763: 112-124.
13. Walker, J. M., W. D. Bowen & F. O. Walker. 1990. Sigma receptors: Biology and function. Pharmacol. Rev. 42: 355-402.
14. 3H]1,3-di(2-tolyl)guanidine binding sites in porcine gastric fundic mucosa. J. Pharmacol. Exp. Ther. 269: 905-910.
15. 3H]-Idazoxan binding sites (I-receptors) occurs to interacting or interconvertible affinity forms of receptor. Pharmacol. Toxicol. 70: 208-219.
16. Regunathan, S., M. P. Meeley & D. J. Reis. 1993. Expression of non-adrenergic imidazoline sites in chromaffin cells and mitochondrial membranes of bovine adrenal medulla. Biochem. Pharmacol. 45: 1667-1675.
17. 3H]RX821002 (2-methoxy-idazoxan) in the human and rat brains. J. Pharmacol. Exp. Ther. 264: 1187-1197.
18. 2-imidazoline sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 350: 252-257.
19. 3H]SKF-10,047 to σ sites. Eur. J. Pharmacol. 180: 361-364.
20. 3H]1,3-di(2-tolyl)guanidine (DTG)-defined σ recognition sites in guinea pig brain. Life Sci. 50: PL65-PL70.
21. 2 binding sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 354: 245-252.
22. Meeley, M. P., P. R. Ernsberger, A. R. Granata & D. J. Reis. 1986. An endogenous clonidine-displacing substance from bovine brain: Receptor binding and hypotensive actions in the ventrolateral medulla. Life Sci. 38: 1119-1126.
23. Atals, D. 1991. Clonidine-displacing substance (CDS) and its putative imidazoline receptor. Biochem. Pharmacol. 41: 1541-1549.
24. Felsen, D., P. Ernsberger, M. P. Meeley & D. J. Reis. 1987. Clonidine displacing substance is biologically active on smooth muscle. Eur. J. Pharmacol. 142: 453-455.
25. Medgett, I. C. & M. W. McCulloch. 1979. Effects of clonidine, guanfacine and three imidazolidine derivatives related to clonidine on blood pressure, heart rate and gastric acid secretion in the anaesthetized rat. Arch. Int. Pharmacodyn. 240: 158-168.
26. Del Tacca, M., G. Soldani, C. Bernardini, E. Martinotti & M. Impicciatore. 1982. Pharmacologic studies on the mechanisms underlying the inhibitory and excitatory effects of clonidine on gastric acid secretion. Eur. J. Pharmacol. 81: 255-261.
27. Bhandare, P. M., P. V. Rataboli & R. S. D. D'Souza. 1991. Dual action of clonidine on ethanol-induced gastric lesions: is the imidazoline-preferring receptor involved? Eur. J. Pharmacol. 199: 243-245.
28. Glavin, G. B., M. A. Carlisle & D. D. Smyth. 1995. Agmatine, an endogenous imidazoline receptors agonist, increases gastric secretion and worsens experimental gastric mucosal injury in rats. J. Pharmacol. Exp. Ther. 274: 741-744.
29. Li, G., S. Regunathan, C. J. Barrow, J. Eshraghi, R. Cooper & D. J. Reis. 1994. Agmatine: An endogenous clonidine-displacing substance in the brain. Science 263: 966-969.
30. Berglindh, T. 1977. Potentiation by carbachol and aminophylline of histamine-and db-cAMP-induced parietal cell activity in isolated gastric glands. Acta Physiol. Scand. 99: 75-84.
31. Chew, C. S. 1994. Parietal cell culture: New models and directions. Annu. Rev. Physiol. 56: 445-461.
32. Purcell, W. M., K. M. Doyle, L. Bagga & M. Derks. 1994 Histamine release from mast cells by polyamines: An NMDA receptor-mediated event? Biochem. Soc. Trans. 22: 398S.
33. Morris, D. R. & A. B. Pardee. 1966. Multiple pathways of putrescine biosynthesis in Escherichia coli. J. Biol. Chem. 241: 3129-3135.
34. Mercenier, A., J. P. Simon, D. Haas & V. Stalon. 1980. Catabolism of L-arginine by Pseudomonas aeruginosa. J. Gen. Microbiol. 116: 381-389.
35. Tabor, C. & H. Tabor. 1985. Polyamines in microorganisms. Microbiol. Rev. 49: 81-99.
36. Panagiotidis, C., S. Blackburn, K. B. Low & E. S. Canellakis. 1987. Biosynthesis of polyamines in ornithine decarboxylase, arginine decarboxylase, and agmatine ureohydrolase deletion mutants of Escherichia coli strain K-12. Proc. Natl. Acad. Sci. USA 48: 4423-4427.
37. Raasch, W., S. Regunathan, G. Li & D. J. Reis. 1995. Agmatine, the bacterial amine, is widely distributed in mammalian tissues. Life Sci. 56: 2319-2330.
38. El-Omar, E. M., D. Penman, J. E. S. Ardill, R. S. Chittajallu, C. Howie & K. E. L. McColl. 1995. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 109: 681-691.
39. Konturek, P. C. H., J. W. Konturek & S. J. Konturek. 1996. Review Articles: Gastric secretion and the pathogenesis of peptic ulcer in the Helicobacter pylori infection. J. Physiol. Pharmacol. 47: 5-19.
40. McGowan, C. C., T. L. Cover & M. J. Blaser. 1996. Helicobacter pylori and gastric acid: Biologic and therapeutic implication. Gastroenterology 110: 926-938.
41. Laszewicz, W., A. Zarembas-Woroniecka & A. Gabryelewicz. 1997. Helicobacter pylori infection and gastric seceretion in duodenal and gastric ulcer patients: The effect of eradication after one year. J. Physiol. Pharmacol. 48: 353-364.
42. Beil, C. W. 1995. Helicobacter pylori and its fatty acids stimulate parietal cell protein kinase C. Naunyn-Schmiedeberg's Arch. Pharmacol. 351: R121.
43. α-methylhistamine. Gastroenterology 108: 959-966.
44. Sobhani, I., A. Bado, Y. Cherifi, L. Moizo, J. P. Laigneau, D. Pospai, M. Mignon & M. J. M. Lewin. 1996. Helicobacter pylori stimulates gastric acid secretion via platelet activating factor. J. Physiol. Pharmacol. 47: 177-185.
45. Tomb, J. F., O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D. Fleischmann, K. A. Ketchum, H. P. Klenk, S. Gill, B. A. Dougherty, K. Nelson, J. Quackenbush, L. Zhou, E. F. Kirkness, S. Peterson, B. Loftus, D. Richardson, R. Dodson, H. G. Kkalak, A. Glodek, K. McKenney, L. M. Fitzegerald, N. Lee, M. D. Adams, E. K. Hickey, D. E. Berg, J. D. Gocayne, T. R. Utterback, J. D. Peterson, J. M. Kelley, M. D. Cotton, J. M. Weidman, C. Fujii, C. Bowman, L. Watthey, E. Walinn, W. S. Hayes, M. Borodovsky, P. D. Karp, H. O. Smith, C. M. Fraser & J. C. Venter. 1997. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388: 539-547.
46. Molderings, G. J., M. Göthert, J. Homann & M. Nilius. 1998. Potential relevance of agmatine for the pathogenesis of gastric mucosal lesions. Naunyn-Schmiedeberg's Arch. Pharmacol. 357: R166.
47. Han, S. R., H. J. Schreiber, S. Bhakdi, M. Loos & M. J. Maeurer. 1998. VacA genotypes and genetic diversity in clinical isolates of Helicobacter pylori. Clin. Diagn. Lab. Immunol. 5: 139-145.
48. McColl, K. E. L. & E. El-Omar. 1993. Effect of H. pylori infection on gastrin and gastric acid secretion. In Helicobacter pylori. Basic Mechanisms to Clinical Cure. R. H. Hunt & G. N. J. Tytgat, Eds.: 245-256. Proc. Int. Symp. Amelia Island, Florida, USA, November 3-6, 1993.
49. Peterson, W. L. 1996. Gastrin and acid in relation to Helicobacter pylori. Aliment. Pharmacol. Therapeut. 10: 97-102.
50. Regunathan, S. & D. J. Reis. 1996. Imidazoline receptors and their endogenous ligands. Annu. Rev. Pharmacol. Toxicol. 36: 511-544.
51. Gilad, G. M. & V. H. Gilad. 1992. Commentary polyamines in neurotrauma: Ubiquitous molecules in search of a function. Biochem. Pharmacol. 44: 401-407.
52. Messa, C., A. Di Leo, B. Greco, L. Caradonna, L. Amati, M. Linsalata, I. Giorgio & E. Jirillo. 1996. Successful eradicating treatment of Helicobacter pylori in patients with chronic gastritis: Gastric levels of cytokines, epidermal growth factor and polyamines before and after therapy. Immunopharmacol. Immunotoxicol. 18: 1-13.
53. Marton, L. J. & A. E. Pegg. 1995. Polyamines as targets for therapeutic intervention. Ann. Rev. Pharmacol. Toxicol. 35: 55-91.
54. Berdinskikh, N. K., N. A. Ignatenko, S. P. Zaletok, K. P. Ganina & V. A. Chorniy. 1991. Ornithine decarboxylase activity and polyamine content in adenocarcinomas of human stomach and large intestine. Int. J. Cancer 47: 496-498.
55. Levenque, J., F. Burtin, V. Catros-Quemener, R. Havous & J. P. Moulinoux. 1998. The gastrointestinal polyamine source depletion enhances DMFO induced polyamine depletion in MCF-7 human breast cancer cells in vivo. Anticancer Res. 18: 263-268.
56. Blachier, F., M. Selamnia, V. Robert, H. M'Rabet-Touil & P. H. Duèe. 1995. Metabolism of L-arginine through polyamine and nitric oxidase synthase pathways in proliferative or differentiated human colon carcinoma cells. Biochim. Biophys. Acta 1268: 255-262.